AU3695295A - Neurotrophin antagonists - Google Patents
Neurotrophin antagonistsInfo
- Publication number
- AU3695295A AU3695295A AU36952/95A AU3695295A AU3695295A AU 3695295 A AU3695295 A AU 3695295A AU 36952/95 A AU36952/95 A AU 36952/95A AU 3695295 A AU3695295 A AU 3695295A AU 3695295 A AU3695295 A AU 3695295A
- Authority
- AU
- Australia
- Prior art keywords
- neurotrophin
- antagonists
- neurotrophin antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CA1995/000603 WO1997015593A1 (en) | 1995-10-25 | 1995-10-25 | Neurotrophin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3695295A true AU3695295A (en) | 1997-05-15 |
Family
ID=4173110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36952/95A Abandoned AU3695295A (en) | 1995-10-25 | 1995-10-25 | Neurotrophin antagonists |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3695295A (en) |
WO (1) | WO1997015593A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291247B1 (en) | 1994-05-11 | 2001-09-18 | Queen's University At Kingston | Methods of screening for factors that disrupt neurotrophin conformation and reduce neurotrophin biological activity |
AU769166B2 (en) * | 1998-04-24 | 2004-01-15 | Genentech Inc. | Fizz proteins |
FR2807660A1 (en) * | 2000-04-13 | 2001-10-19 | Warner Lambert Co | Use of a nerve growth factor antagonist for the manufacture of a medicament for the prevention or treatment of chronic visceral pain |
US7255860B2 (en) | 2002-10-08 | 2007-08-14 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody |
BR0315164A (en) | 2002-10-08 | 2005-08-23 | Rinat Neuroscience Corp | Methods for treating postoperative pain by administering a nerve growth factor antagonist and compositions containing the same |
UA80447C2 (en) | 2002-10-08 | 2007-09-25 | Methods for treating pain by administering nerve growth factor antagonist and opioid analgesic | |
AU2003299898B2 (en) | 2002-12-24 | 2010-12-16 | Rinat Neuroscience Corp. | Anti-NGF antibodies and methods using same |
US9498530B2 (en) | 2002-12-24 | 2016-11-22 | Rinat Neuroscience Corp. | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
US7569364B2 (en) | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
WO2004073653A2 (en) | 2003-02-19 | 2004-09-02 | Rinat Neuroscience Corp. | Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
PL1732949T3 (en) | 2004-04-07 | 2010-06-30 | Rinat Neuroscience Corp | Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
JP4861686B2 (en) * | 2005-11-17 | 2012-01-25 | ライオン株式会社 | Neurotrophin-4 antagonist |
WO2012024650A2 (en) | 2010-08-19 | 2012-02-23 | Abbott Laboratories | Anti-ngf antibodies and their use |
AU2013271564A1 (en) | 2012-06-06 | 2014-12-04 | Zoetis Services Llc | Caninized anti-NGF antibodies and methods thereof |
BR112020017701A2 (en) | 2018-03-12 | 2020-12-29 | Zoetis Services Llc | ANTI-NGF ANTIBODIES AND METHODS OF THE SAME |
US20230348608A1 (en) | 2022-04-27 | 2023-11-02 | Regeneron Pharmaceuticals, Inc. | Treatment Of Arthropathy Based Upon Stratification Of Osteoarthritis Polygenic Risk Score |
WO2024196744A1 (en) | 2023-03-17 | 2024-09-26 | Regeneron Pharmaceuticals, Inc. | Proteomic risk score for osteoarthritis (oa) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9402331D0 (en) * | 1994-02-07 | 1994-03-30 | Univ Mcgill | Nerve growth factor structural analogs and their uses |
-
1995
- 1995-10-25 AU AU36952/95A patent/AU3695295A/en not_active Abandoned
- 1995-10-25 WO PCT/CA1995/000603 patent/WO1997015593A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997015593A1 (en) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2524995A (en) | Neurokinine (tachykinine) antagonists | |
AU5235796A (en) | o-hydroxyphenyl-s-triazines | |
AU4780896A (en) | Core-board | |
AU6000496A (en) | Phenylpyridazinones | |
AU5896396A (en) | Pyridine-microbicides | |
AU1030997A (en) | Taphane | |
HU9601176D0 (en) | Adhesion-receptor antagonists | |
AU6856796A (en) | Des-arg9-bk antagonists | |
AU3695295A (en) | Neurotrophin antagonists | |
AU4996696A (en) | 2-benzyl-3-arylbenzothiophenes | |
AU5147496A (en) | Fucopeptides | |
AU6235496A (en) | Azothiophenes | |
AU5593896A (en) | Benzisothiazolyl-substituted aminomethylchromans | |
AU5500196A (en) | Anti-transpirants | |
AU4382896A (en) | Acetylimidazobenzodiazepines | |
AU5108596A (en) | Morphine-3-esters | |
AU5917896A (en) | Poly-beta-1-4-N-acetylglucosamine | |
AU6215196A (en) | Piperidinylmethyloxazolidinones | |
AU6298496A (en) | Fitting | |
AU5013796A (en) | Wireclamp | |
AU5107096A (en) | Haemodialyser | |
AU6840796A (en) | Sack-holder | |
AU4974596A (en) | Betide-substituted gnrh antagonists | |
AU6658396A (en) | Polyhydroxyalkylamidobetaine | |
AU2012697A (en) | Bottle-opener |